French Biotech Company AdipoPharma Secures Funding to Initiate Clinical Trials for its first-in-class compound for Insulin Resistance

Contributed by: GlobeNewswire

Tags

diabetes

More Like This

AdipoPharma Advances PATAS into Phase 1b Clinical Trial in Patients with Type 2 Diabetes

PR Newswire associated0

Ousia Pharma Secures Substantial Seed Financing Led by Omega Funds to Advance Groundbreaking Obesity Treatment

SIBIONICS and PharmaSens Explore New Horizons for Automated Insulin Delivery at EASD 2026

Tiziana Life Sciences Files New Patent Application for Combination Therapy of anti-CD3 (Foralumab) with GLP-1 Receptor Agonist for Additional Reduction of Obesity - Associated Inflammation

Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant

François Ravenelle, PhD, President and Chief Executive Officer of Innospera Pharma

François Ravenelle, PhD Appointed President and CEO of Innospera Pharma to Lead Next Phase of Growth

VASTHERA Receives U.S. FDA Clearance to initiate Phase 1 Clinical Trial of Pulmonary Arterial Hypertension Drug Candidate, VTB-10

Brenus Pharma, Winner of the Call for Proposals "Innovations in Biotherapies and Bioproduction for France 2030", Receives €5 Million for Its Anticancer Vaccine Immunotherapy